Charles Joel Rosser, M.D.
Contact Information
- Present Title
- Assistant Professor
- Citizenship
- USA
- Office
- University of Florida/Shands
Department of Urology
University of Florida
N2-3, PO Box Box 100247
Gainesville, FL 32610-0247
Email: charles.rosser@urology.ufl.edu
Phone: 352-273-7647
Fax: 352-392-8846
Cellphone: 713-806-3973
Back to Top
Work Experience/Service
- Current Appointment
- University of Florida Urology Assistant Professor July 2003-present
University of Florida Pharmacology & Therapeutics January 2007-present
Back to Top
Education and Training
- Fellowship
- Urologic Oncology July 2000- June 2003
University of Texas MD Anderson Cancer Center
Houston, TX 77030
American Foundation of Urologic Disease Scholar
- Residency
- Urology July 1996- June 2000 Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina 27157
General Surgery July 1994- June 1996 Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina 27157
- Medical School
- Doctor of Medicine, May 1994
Robert Wood Johnson Medical School
New Brunswick, New Jersey 07054
- College
- Bachelor of Science, May 1990
Fairleigh Dickinson University
Madison, New Jersey 07021
Graduated Summa Cum Laude
Back to Top
Summary of Qualifications
- American Urologic Board Certified
- Florida Medical License (Active)
- Texas Medical License (Active)
- North Carolina Medical License (Active)
Back to Top
Military
- LCDR. United States Naval Reserves. Greensboro, North Carolina. December, 1996- 2005 (Honorable discharge)
Back to Top
Honors and Awards
- University of Florida Research Day (2007)-
Best Clinical Research- Pendleton JM, Tan WW, Anai S, Shiverick K, Chang M, Hou W, Rosser CJ. Phase II Trial of Isoflavone in Prostate-Specific-Antigen Recurrent Prostate Cancer after Definitive Therapy
- Best Basic Science Research- Anai S, Brown BD, Nakamura K, Goodison S, Hirao Y, Rosser CJ. Irradiation of Human Prostate Cancer Cells Increases Uptake of Antisense Oligodeoxynucleotide.
- University of Florida Research Day (2005)-
1st Prize Basic Science Anai S, Goodison S, Shiverick K, Iczkowski K, Tanaka M, Rosser CJ. Combination of PTEN gene therapy and radiation inhibits the growth of human prostate cancer xenografts.
2nd Prize Basic Science Ketcham CM, Anai S, Reutzel R, Sheng S, Schuster SM, Brenes RB, Agbandje-McKenna M, McKenna R, Rosser CJ, Boehlein SK. P37 induces tumor invasiveness.
- Dean’s Fund: Neoadjuvant Abarelix in High Risk Prostate Cancer Patients undergoing Prostatectomy 2004 (Award amount $10,000)
- American Foundation of Urologic Disease Scholarship for The Use of Mutated RB Gene in an Adenoviral Vector in the Treatment of Superficial Bladder Cancer, 2000-2002.
- First Prize for Resident/Fellow Poster Presentation: Resident's and Fellow's Research Day 1999
Back to Top
Professional Membership
- American Association of Clinical Urologists-1999
- American Association for Cancer Research-1998
- Southeastern Section of the American Urologic Association, Inc.-1995
- American Urologic Association, Inc.-1995
- Society of Urologic Oncology-2000
- Society of Basic Urologic Research-2004
- Florida Medical Association-2004
- American College of Surgeons-2006
Back to Top